JENIA HARRIS: Open Payments
NPI 1033660584 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 44 payments from 9 companies in 2025. Trend: 2023 $593 · 2024 $858 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $324 |
| Teva Pharmaceuticals USA, Inc. | 10 | $200 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Alkermes, Inc. | 4 | $97 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Almatica Pharma LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: VRAYLAR, AUSTEDO XR, SPRAVATO, ARISTADA, Auvelity, REXULTI, INGREZZA, LOREEV XR.
Industry payments across LA — which companies pay providers there.
